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Lung epithelial cells are the primary cellular targets for respiratory virus pathogens such as influenza and parainfluenza viruses. Here, we have
analyzed influenza A, influenza B and Sendai virus-induced chemokine response in human A549 lung epithelial cells. Influenza virus infection
resulted in low CCL2/MCP-1, CCL5/RANTES, CXCL8/IL-8 and CXCL10/IP-10 production at late times of infection. However, when cells were
pretreated with TNF-a or IFN-a, influenza-A-virus-induced chemokine production was greatly enhanced. Cytokine pretreatment resulted in
enhanced expression of RIG-I, IKK(, interferon regulatory factor (IRF)1, IRF7 and p50 proteins. Most importantly, influenza-A-virus-induced
DNA binding of IRF1, IRF3, IRF7 and NF-nB onto CXCL10 ISRE and NF-nB elements, respectively, was markedly enhanced in cytokine-
pretreated cells. Our results suggest that IFN-a and TNF-a have a significant role in priming epithelial cells for higher cytokine and chemokine
production in influenza A virus infection.
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Influenza viruses are enveloped negative-stranded RNA
viruses that cause significant morbidity throughout the
world. The primary targets of influenza viruses are the
epithelial cells of the upper respiratory tract. However,
influenza viruses can also infect macrophages and dendritic
cells (Coccia et al., 2004; Julkunen et al., 2000; O¨sterlund et
al., 2005; Pirhonen et al., 1999). Virus-induced chemokines
and cytokines have a major role in recruiting leukocytes to
the site of inflammation and activating innate immune
responses. Influenza-A-virus-infected lung epithelial cells
have been shown to produce at least low levels of type I
IFNs (Ronni et al., 1997) and CCL2/MCP-1, CCL5/
RANTES, CCL11/eotaxin and CXCL8/IL-8 (Adachi et al.,
1997; Kawaguchi et al., 2000; Matsukura et al., 1996). IL-6,
TNF-a, CCL2, CCL3/MIP-1a, CCL4/MIP-1h and CXCL80042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.09.043
* Corresponding author. Fax: +358 9 47448355.
E-mail address: ville.veckman@ktl.fi (V. Veckman).have also been detected in the nasopharyngeal secretions of
influenza-A-virus-infected patients (Fritz et al., 1999; Kaiser
et al., 2001; Skoner et al., 1999).
Type I IFNs and TNF-a have important functions at early
times of virus infection. These include direct antiviral effects
mediated by IFN-a-induced antiviral proteins such as the MxA
(Stark et al., 1998). TNF-a has also been shown to have antiviral
activity in lung epithelial cells (Seo and Webster, 2002). IFN-a
in turn induces IFN-g production in NK and T cells (Matikainen
et al., 2001; Sareneva et al., 1998) and stimulates their cytotoxic
capacity. Furthermore, IFN-a and TNF-a activate macrophages
and stimulate dendritic cell maturation. Proinflammatory cyto-
kines can also enhance host cell responses indirectly by
upregulating the expression of transcription factors involved in
cytokine gene expression. Interferon regulatory factors (IRFs)
and NF-nB are important regulators of virus-induced cytokine
and chemokine production. IRF1 is expressed in various cell
types, and its gene expression is upregulated by type I IFNs,
TNF-a or IL-1 (Fujita et al., 1989; Li et al., 1996). IRF3 is
constitutively expressed in most cell types (Pitha et al., 1998;
Servant et al., 2002), while IRF7 expression is induced by IFN-a6) 96 – 104
www.e
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1998; Sato et al., 1998).
In the present study, we have compared the ability of
different influenza viruses to induce cytokine and chemokine
gene expression in A549 lung epithelial cells. We also used
Sendai virus, which is known to induce strong cytokine and
chemokine responses (Hua et al., 1996; Matikainen et al.,
2000; Pirhonen et al., 1999, 2002; Zidovec and Mazuran,
1999). Both influenza A and B viruses induced a weak
inflammatory cytokine and chemokine response as compared
to Sendai virus. However, significantly enhanced chemokine
gene expression was detected in cells pretreated with TNF-a
or IFN-a prior to influenza A virus infection. This
phenomenon correlated with increased expression of the
components of the RIG-I signaling pathway followed by
enhanced activation of IRF and NF-nB family of transcrip-
tion factors.
Results
Virus-induced expression of TNF-a and chemokine mRNAs in
A549 cells
Virus-induced TNF-a and chemokine gene expression was
first analyzed at mRNA level by Northern blotting. A549 cells
were left uninfected or infected with influenza or Sendai
viruses, and total cellular RNA was collected at different time
points. Influenza A H1N1-induced CCL2, CCL5 and CXCL10
mRNA expression was detectable at 24 h after infection, while
influenza A H3N2 and influenza B infection induced CCL2,
CCL5 and CXCL8 mRNA expression already after 12
h infection (Fig. 1). No TNF-a mRNA expression was detected
in influenza virus-infected cells. In contrast to influenza
viruses, Sendai virus induced a rapid activation of TNF-a,
CCL2, CCL5, CXCL8 and CXCL10 gene expression. The
mRNA expression levels remained elevated until 24 h except
for CXCL10, which peaked at 12 h and was downregulated
thereafter.Fig. 1. Virus-induced mRNA expression of cytokine and chemokine genes. A549 cel
H3N2 (A/Beijing/353/89), influenza B/Victoria/2/87 or Sendai viruses (MOI 2) for
cytokine and chemokine genes was analyzed by Northern blotting. Ethidium brom
loading. Results from one representative experiment are shown. IA and IB refer toVirus dose-dependent chemokine production
To evaluate virus-induced chemokine production at protein
level, A549 cells were infected with different virus doses for
24 h, and CCL2, CCL5, CXCL8 and CXCL10 chemokine
levels were analyzed from cell culture supernatants by
ELISA. Although influenza A H1N1 virus induced somewhat
lower chemokine mRNA expression compared to H3N2 or
influenza B viruses, the chemokine production at protein level
was nearly equal for all the influenza viruses tested. The
highest production levels were seen at MOI 25 for influenza
A and influenza B viruses. The production of all the
chemokines analyzed showed a clear influenza virus dose-
dependent production pattern (Fig. 2). Consistent with the
mRNA data, Sendai virus infection resulted in up to 10- to
50-fold higher chemokine production levels as compared to
influenza viruses. The highest CCL2, CXCL8 and CXCL10
production levels were seen with MOI 0.2 to 1 of Sendai
virus (Fig. 2). However, in the case of CCL5, maximal
production was detected when the highest Sendai virus dose
(MOI 25) was used. In spite of high TNF-a mRNA levels,
TNF-a protein production could not be detected in Sendai-
virus-infected cells. It is possible that TNF-a protein
production is also translationally regulated in A549 cells or
that the secreted TNF-a was used up by the cells.
Effect of TNF-a and IFN-a pretreatment on influenza A H3N2
virus-induced TNF-a and chemokine mRNA expression
TNF-a and IFN-a regulate the expression of several
proteins involved in signal transduction and viral recognition.
Thus, we hypothesized that TNF-a or IFN-a pretreatment
might enhance influenza-A-virus-induced low chemokine
responses. A549 cells were pretreated with 10 ng/ml of TNF-
a or 100 IU/ml of IFN-a for 16 h followed by infection with
influenza A H3N2 virus (A/Beijing/353/89). After 12 h of
infection, total cellular RNA was collected and TNF-a and
chemokine gene expression was analyzed by Northern blotting.ls were infected with influenza A H1N1 (A/New Caledonia/20/99), influenza A
the times indicated. Total cellular RNA was isolated, and mRNA expression of
ide staining showing 18S and 28S rRNAs was used to control equal sample
influenza A and B viruses, respectively.
Fig. 2. Virus-induced chemokine production. Cells were left uninfected or infected with influenza or Sendai viruses for 24 h. The highest concentration of virus dose
correlates to MOI 25 for all viruses, and 5-fold serial dilutions were used in the infections. Values are the means of three independent experiments. Error bars
represent standard deviations of the means. IA and IB refer to influenza A and B viruses, respectively.
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undetectable chemokine gene expression. However, in cyto-
kine-pretreated cells, influenza A virus infection induced
expression of TNF-a, CCL2, CCL5, CXCL8 and CXCL10
mRNAs (Fig. 3). TNF-a pretreatment enhanced influenza-A-
virus-induced CCL2 and CXCL10 mRNA expression better
than IFN-a pretreatment, whereas in the case of CXCL8 the
most efficient mRNA expression was detected in IFN-a
pretreated cells. TNF-a pretreatment resulted in some CCL2
and CCL5 mRNA expression also in uninfected cells (Fig. 3).
However, influenza A virus infection further enhanced the
mRNA expression of these chemokines. To evaluate the effect
of TNF-a and IFN-a on virus replication, Northern blot
analysis was carried out for viral mRNA expression. At 12
h post-infection, TNF-a or IFN-a pretreatment had no
significant effect on the mRNA expression levels of influenza
A NP or NS1 genes.
Effect of TNF-a and IFN-a pretreatment on IRF and NF-jB
transcription factor protein expression
To assess the molecular mechanisms of enhanced chemo-
kine gene expression in cytokine-pretreated cells, we analyzed
the effect of TNF-a and IFN-a pretreatment on the expression
of IRF and NF-nB family transcription factors. We also
characterized the expression of RIG-I and IKK-( that are
involved in dsRNA recognition and IRF phosphorylation,
respectively. Cells were treated with TNF-a or IFN-a for 16 h,and protein expression was analyzed by Western blotting. IRF1
protein level was low in untreated A549 cells, but its
expression was significantly upregulated by TNF-a (Fig. 4).
IRF3 expression was not affected by cytokine treatment, while
IRF7 level was enhanced by both TNF-a and IFN-a. TNF-a
also induced the expression of p50, whereas the expression of
p65 was not affected by cytokine pretreatments (Fig. 4). TNF-a
and IFN-a enhanced the expression of RIG-I, while IKK(
protein level was only induced by TNF-a.
Effect of cytokine pretreatment on influenza-A-virus-induced
activation of IRF and NF-jB transcription factors
Since TNF-a and/or IFN-a enhanced the expression of IRF
and NF-nB transcription factors and their upstream regulators
RIG-I and IKK(, we next analyzed whether virus-induced
DNA binding of transcription factors would also be increased
in response to cytokine pretreatment. A549 cells were left
untreated or pretreated with TNF-a or IFN-a for 16 h and
infected with influenza A H3N2 virus (A/Beijing/353/89).
DNA affinity binding experiments were performed by using
ISRE and NF-nB elements from CXCL10 proximal promoter.
Influenza virus-induced IRF1, IRF3 and IRF7 DNA binding
onto CXCL10 ISRE element was significantly enhanced in
cytokine-pretreated cells (Fig. 5A). IRF1 DNA binding peaked
at 6 h post-infection, and the binding was slowly reduced
within 24 h. IFN-a pretreatment resulted in somewhat better
virus-induced IRF1 activation as compared to that in TNF-a-
Fig. 3. The effect of TNF-a and IFN-a pretreatment on virus-induced TNF-a
and chemokine mRNA expression. A549 cells were left untreated or pretreated
with 10 ng/ml of TNF-a or 100 IU/ml of IFN-a for 16 h. After 12 h of
influenza A H3N2 (A/Beijing/353/89) virus infection, total cellular RNA was
collected, and TNF-a and chemokine mRNA expression was analyzed by
Northern blotting. The effect of cytokine pretreatment on virus replication was
analyzed by probing with influenza A virus nucleoprotein (NP) and
nonstructural protein 1 (NS1) cDNA probes. Ethidium bromide staining
showing 18S and 28S rRNAs was used to control equal sample loading. Results
from one representative experiment out of two are shown.
Fig. 4. The effect of cytokine pretreatments on IRF, NF-nB, RIG-I and IKK(
protein expression. Cells were left untreated or treated with 10 ng/ml of TNF-a
or 100 IU/ml of IFN-a for 16 h. Cells were lysed into SDS sample buffer, and
protein levels were analyzed by Western blotting. Results from one represen-
tative experiment out of two are shown.
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untreated cells (Fig. 5A). Influenza virus-induced IRF3
phosphorylation was only detectable in cytokine-pretreated
cells (Fig. 5A). In IFN-a-pretreated cells, maximal IRF3
activation was detectable at 9 h post-infection, whereas, in
TNF-a-pretreated cells IRF3 DNA binding peaked at 12 h.
Cytokine pretreatments also resulted in enhanced virus-induced
IRF7 DNA binding. In cytokine-pretreated cells, IRF7 DNA
binding peaked at 9 h post-infection, while, in untreated cells,
no IRF7 activation was detected. Interestingly, IRF7 DNA
binding was also seen in cytokine-pretreated uninfected cells at
3 h. This binding, however, was not visible anymore after 12 or
24 h. Since both TNF-a and IFN-a enhanced IRF7 protein
expression (Fig. 4), our results suggest that enhanced IRF7
protein expression may result in some DNA binding also in the
absence of additional stimulus at least in this experimental
setting (Fig. 5A).
Enhanced DNA binding of p50 and p65 was seen in cells
pretreated with TNF-a or IFN-a prior to influenza A infection
(Fig. 5B). In untreated cells, virus-induced NF-nB binding was
detectable only at 24 h post-infection. In contrast, influenza
virus-induced NF-nB binding was visible already after 9 h in
cytokine-pretreated cells.
Although the mRNA expression of viral genes was not
clearly affected by cytokine pretreatment at 12 h (Fig. 3), we
evaluated the effect of cytokine pretreatment on influenza A
NS1 protein expression in more detail. Cells were left untreated
or pretreated with TNF-a or IFN-a followed by influenza Avirus infection. The kinetics of NS1 expression was analyzed
by Western blotting. In untreated cells, NS1 protein expression
was detected after 3 h, and the levels increased towards 24 h. In
IFN-a or TNF-a-pretreated cells, NS1 protein production was
reduced and detectable only after 6 h infection (Fig. 5C).
Role of influenza A NS1 in chemokine gene expression
Influenza A virus has developed means to counteract the
host cell antiviral response. This effect is mediated by the viral
NS1 protein that can interfere with host cell cytokine
production by reducing the synthesis and/or interfering with
the posttranslational processing of the host cell pre-mRNAs
(Noah et al., 2003; Talon et al., 2000). To analyze the role of
NS1 in the cytokine priming effect, we performed experiments
with recently created influenza NS1 CPSF mutant virus (Noah
et al., 2003). A549 cells were pretreated with IFN-a or TNF-a
for 16 h followed by infection with influenza A/Udorn/72 wt,
Udorn NS1 CPSF mutant or influenza A/Beijing/353/89
viruses (MOI 2). After 6 h of infection, total cellular RNA
was isolated, and the expression of CCL5 and CXCL10
mRNAs was analyzed by Northern blotting.
Pretreatment of cells with TNF-a or IFN-a clearly enhanced
CCL5 and CXCL10 mRNA expression by all viruses (Fig.
6A). Somewhat higher CCL5 and CXCL10 mRNA expression
was seen in cytokine-pretreated cells infected with the
influenza A Udorn CPSF mutant virus as compared to the wt
virus. Influenza A Beijing virus induced lower CCL5 and
CXCL10 mRNA expression compared to the Udorn viruses.
To control equal virus infectivity and the effect of cytokine
pretreatments on virus replication, mRNA expression of
influenza NS1 and NP genes was analyzed by Northern
blotting. In the absence of cytokine pretreatment, viral NS1
and NP mRNA levels were equal for all viruses. IFN-a
pretreatment reduced the expression of NP and NS1 mRNAs to
some extent (Fig. 6A). CXCL10 protein production was
analyzed by ELISA from cell culture supernatants collected
Fig. 5. Effect of cytokine pretreatment on influenza-A-virus-induced activation of transcription factors. A549 cells were left untreated or pretreated with TNF-a or
IFN-a for 16 h followed by influenza A H3N2 (A/Beijing/353/89) virus infection (2 PFU/cell). Whole cell lysates were subjected to DNA affinity binding assay by
using ISRE or NF-nB elements from CXCL10 promoter. DNA bound proteins were separated by SDS-PAGE and stained with transcription factor-specific
antibodies. (A) Kinetics of influenza-A-virus-induced DNA binding of IRF1 (top panel), IRF3 (middle) and IRF7 (bottom) onto CXCL10 ISRE element. (B)
Kinetics of influenza-A-virus-induced DNA binding of p50 (top panel) and p65 (bottom) onto CXCL10 NF-nB element. (C) Effect of TNF-a and IFN-a
pretreatment on the expression of influenza A virus NS1 protein. Western blot analysis of whole cell lysates.
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virus induced significant CXCL10 production in the absence of
cytokine pretreatment. However, TNF-a or IFN-a pretreatment
dramatically enhanced virus-induced CXCL10 in the case of all
influenza viruses (Fig. 6B).
Discussion
In the current study we show that influenza A and B viruses
induce only weak cytokine and chemokine response in human
A549 lung epithelial cells. Most importantly, we demonstrate
here that influenza-A-virus-induced chemokine response can
be greatly enhanced by pretreating cells with TNF-a or IFN-a
prior to virus infection. In contrast to influenza viruses, Sendai
virus infection resulted in a rapid and strong chemokine
production, which was not further enhanced by cytokine
pretreatment (data not shown).
The transcription of several inflammatory chemokine genes
is regulated at the proximal promoter level by NF-nB and IRF
transcription factors. In this report, we show that TNF-a and
IFN-a enhance the expression and virus-induced activation of
these transcription factors, thus providing one mechanistic
explanation for the enhanced chemokine production seen in
cytokine-pretreated cells. TNF-a pretreatment resulted in
enhanced expression of IRF1, IRF7 and p50 proteins, while
IFN-a pretreatment resulted in elevated levels of IRF7. These
results are in line with previous reports (Au et al., 1998; Fujita
et al., 1989; Lehtonen et al., 1997; Marie et al., 1998; Pitha et
al., 1998; Sato et al., 1998). Cytokine pretreatments also
enhanced the expression of RIG-I and IKK( (only TNF-a),which mediate dsRNA recognition and IRF phosphorylation,
respectively (Sharma et al., 2003; Yoneyama et al., 2004). RIG-
I has previously been identified as an IFN-inducible gene
(Yoneyama et al., 2004), whereas the ability of TNF-a to
induce both RIG-I and IKK( in lung epithelial cells is a novel
finding. In human macrophages, IFN-a enhances the expres-
sion of Toll-like receptor (TLR)3, TLR7, and several TLR
adaptor molecules (Miettinen et al., 2001; Siren et al., 2005),
but their role in epithelial cells during influenza A virus
infection has remained elusive. In conclusion, our results
demonstrate that cytokine pretreatment enhances the expres-
sion of host cell signaling molecules involved in viral
recognition, signal transduction and antiviral gene expression.
Virus-induced activation and DNA binding of transcription
factors were analyzed by DNA affinity binding experiments. In
this study, we focused on the regulation of CXCL10. This
chemokine attracts activated NK and Th1 cells (Bonecchi et al.,
1998; Inngjerdingen et al., 2001; Sallusto et al., 1998), which
have an essential role in the clearance of virus infection. The
CXCL10 promoter contains ISRE and NF-nB regulatory
elements, and it has been demonstrated that TNF-a together
with IFN-a or IFN-g can synergistically enhance CXCL10
expression (Ohmori and Hamilton, 1993; Veckman et al.,
2003). In our experimental system, influenza A virus infection
as such resulted in weak or no binding of IRF3 and IRF7 onto
CXCL10 ISRE element. Similarly, influenza-A-virus-induced
DNA binding of p50 and p65 onto CXCL10 NF-nB element
was only detectable at late stages of infection. However, TNF-
a or IFN-a treatment prior to influenza A virus infection
resulted in a significantly increased activation and DNA
Fig. 6. The role of influenza A NS1 protein in virus-induced cytokine gene
expression. (A) A549 cells were pretreated with TNF-a or IFN-a for 16
h followed by infection with influenza A H3N2 Udorn wt, influenza A H3N2
Udorn NS1 CPSF mutant or influenza A H3N2 Beijing viruses for 6 h. The
expression of CCL5, CXCL10, influenza NP and NS1 genes was analyzed by
Northern blotting. (B) Cells were pretreated as above, and cell culture
supernatants were collected at 24 h after infection. CXCL10 levels were
determined by ELISA. Error bars represent standard deviations of the means
(n = 4).
Fig. 7. Schematic model of cytokine priming on influenza-A-virus-induced host
cell responses. (1) Primary influenza A virus infection results in a weak
cytokine and chemokine production in human lung epithelial cells. (2)
However, virus-infected macrophages and dendritic cells, which reside in
close proximity to epithelium, can produce significant amounts of TNF-a and
type I IFNs in response to influenza A infection. These cytokines may act
locally in virus-infected tissues to enhance the expression of proteins involved
in virus recognition and signal transduction. (3) Ultimately, the cytokine
priming leads to a strong virus-induced activation of transcription factors and
enhanced secondary cytokine and chemokine response at later phases of
influenza A virus infection. The strong cytokine and chemokine response
enhances the activation of antiviral response and recruitment of leukocytes to
the site of inflammation, which results in the clearance of the virus infection.
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such effect was seen except in the case of IRF7. The last
observation is also of interest since it suggests that IRF7, even
in the absence of virus infection, may have some intrinsic DNA
binding activity without enhancing transcription at least in this
experimental setting.
Influenza A virus has developed means to inhibit the
activation of host cell immune response. Several models of
the molecular mechanisms of NS1-mediated inhibition of IFN
synthesis have been proposed (Noah et al., 2003; Talon et al.,
2000). It has been demonstrated that NS1 protein inhibits
cytokine and chemokine responses by interfering with the
post-transcriptional processing and stability of host cell
antiviral (and all RNA polymerase II synthesized) pre-
mRNAs (Noah et al., 2003). In addition, it has been
suggested that NS1 protein can inhibit the activation and
nuclear translocation of IRF3 (Talon et al., 2000). In this
study, we used recently described influenza A NS1 CPSF
mutant virus (Noah et al., 2003). Consistent with previous
observations made on type I IFN gene expression (Noah et
al., 2003), CPSF mutant virus induced higher expression of
CCL5 and CXCL10 as compared to wt Udorn or Beijingviruses (Fig. 6). Similar to the wt viruses, the chemokine
response induced by Udorn CPSF mutant virus was signif-
icantly enhanced by TNF-a or IFN-a pretreatment (Fig. 6).
Although cytokine pretreatments had only a minor effect on
the viral gene expression at mRNA level, NS1 protein
expression was delayed and reduced in TNF-a and IFN-a-
pretreated cells (Fig. 5). Thus, cytokine-mediated reduction of
NS1 protein production together with the enhanced expres-
sion of host cell signaling molecules may contribute to the
greatly enhanced chemokine gene expression seen in cyto-
kine-pretreated cells. However, the interference of RNA
polymerase function by NS1 protein is likely to contribute
to inhibition of host antiviral responses when cells have not
been exposed to TNF-a or IFN-a as seen in the case of
CXCL10 protein production (Fig 6B). It is probable that NS1
protein can inhibit host cell antiviral response at multiple
levels. Further studies using different NS1 mutant viruses and
transfection constructs are, however, warranted to reveal the
molecular mechanisms of action of NS1 protein.
In the present study, we show that influenza A and B
viruses induce a weak chemokine expression in human lung
epithelial cells. The lack of significant production of
chemokines is likely to be advantageous for influenza viruses.
By avoiding chemokine production and subsequent recruit-
ment of leukocytes to the site of infection, influenza viruses
may have a replication advantage before the host inflamma-
tory and antiviral responses are activated. Influenza-A-virus-
induced chemokine response can be markedly enhanced by
pretreating cells with TNF-a or IFN-a. The mechanism of the
pretreatment effect is likely to be complex and function at
multiple levels. As we demonstrate here, TNF-a and IFN-a
pretreatment enhanced both the expression and virus-induced
activation of IRF and NF-nB transcription factors that
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of upstream components RIG-I and IKK( was enhanced by
TNF-a and/or IFN-a.
The priming effect is likely to be important in vivo.
Although A549 cells did not show detectable TNF-a produc-
tion in response to influenza A or B virus infection, we and
others have previously demonstrated that macrophages and
dendritic cells produce TNF-a and type I IFNs during influenza
A virus infection (Cella et al., 2000; Coccia et al., 2004;
O¨sterlund et al., 2005; Pirhonen et al., 1999, 2001; Sareneva et
al., 1998). Since macrophages and DCs are in close proximity
to the epithelium, APC-derived proinflammatory cytokines
may enhance the antiviral capacity of local epithelium during
influenza virus infection, thus resulting in enhanced clearance
of virus infection (summarized in Fig. 7).
Materials and methods
Cell cultures and viruses
The A549 lung adenocarcinoma cell line (ATCC CCL-185)
was obtained from American Type Culture Collection (ATCC,
Manassas, VA). Cells were grown in plastic cell culture flasks
(Falcon, Becton Dickinson, Franklin Lakes, NJ) in Eagle-
MEM (Sigma Chemical Co, St. Louis, MO) supplemented with
2 mM penicillin, 0.6 Ag/ml of streptomycin and 10% fetal calf
serum (FCS) (Integro, Zaandam, The Netherlands).
Influenza A H1N1 (A/New Caledonia/20/99), influenza A
H3N2 (A/Beijing/353/89), influenza B (B/Victoria/2/87) and
Sendai (strain Cantell) viruses were grown in 11-day-old
embryonated eggs as previously described (Ronni et al., 1995).
The hemagglutination titers of influenza A H1N1 and H3N2
virus stocks were 128, influenza B was 256 and Sendai virus
stock was 4096.
The infectivity of virus stocks was determined by
immunofluorescence microscopy. A549 cells were cultured
on glass coverslips and infected with different dilutions of
influenza or Sendai virus stocks for 18 h. Fixed cells were
stained with polyclonal rabbit anti-influenza H3N2, anti-
H1N1, anti-influenza B or anti-Sendai antisera (Julkunen et
al., 1983; Keskinen et al., 1999) followed by staining with
fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG
antibodies (Boehringen, Mannheim, Germany). The percent-
age of virus-positive cells was determined by immunofluo-
rescence microscopy. Influenza A H1N1 and H3N2 virus
stocks showed similar infectivity of 2  107 PFU/ml. The
infectivity titers of influenza B and Sendai virus stocks were
4  107 PFU/ml. The used multiplicity of infection (MOI) is
indicated in each experiment. To assess the role of influenza
A virus nonstructural protein 1 (NS1) in chemokine gene
expression, wild type influenza A/Udorn/72 (H3N2) (2 
107 PFU/ml) and influenza A/Udorn/72 CPSF mutant (1 
107 PFU/ml) viruses were used. Influenza A/Udorn/72 CPSF
mutant virus has a mutation in NS1 gene that prevents the
interaction of NS1 protein with the 30 kDa subunit of the
cleavage and polyadenylation specificity factor (CPSF)
(Noah et al., 2003).Stimulation experiments
Virus infections were done in Eagle-MEM containing
antibiotics and 2% FCS. Viruses were allowed to adhere to
A549 cells for 1.5 h, after which the culture media was
changed. Cells and cell culture supernatants were collected at
different times and used for RNA, protein or ELISA analyses.
In some experiments, cells were pretreated with TNF-a (10 ng/
ml; R&D Biosystems, Abingdon, United Kingdom) or purified
leukocyte IFN-a (100 IU/ml; Finnish Red Cross Blood
Transfusion Service, Helsinki, Finland) for 16 h after which
the culture media was changed and cells were left uninfected or
infected with different viruses as indicated in each experiment.
RNA extraction and Northern blotting
Total cellular RNA was extracted by the guanidine
isothiocyanate method as previously described (Chirgwin et
al., 1979). RNA was isolated by centrifugation through a CsCl
cushion (Glisin et al., 1974), and the RNA concentrations of
the samples were quantitated spectrophotometrically. Equal
amounts of RNA (10 Ag) were separated by size in 1%
formaldehyde agarose gels and blotted to Hybond-N mem-
branes (Amersham Biosciences, Buckinghamshire, United
Kingdom). The cDNA probes used to detect the mRNA
expression of TNF-a, CCL2, CCL5, CXCL8 and CXCL10
have been previously described (Matikainen et al., 2000). The
probes for influenza nucleoprotein (NP) and nonstructural
protein 1 (NS1) genes were kindly provided by Dr. R. Krug
(Univ. of Texas at Austin). The cDNA probes were labeled
with [a-32P]ATP (3000 Ci/mmol, Amersham Biosciences) by a
random-primed DNA labeling kit. Membranes were hybridized
overnight in Ultrahyb buffer (Ambion, Austin, TX) at +42 -C.
After hybridization, membranes were washed three times with
1 SSC, 0.1% SDS at +42 -C and once at +65 -C. Membranes
were exposed to Kodak X-Omat AR films (Eastman Kodak,
Rochester, NY) at 70 -C with intensifying screens.
Cytokine and chemokine ELISAs
Cytokine and chemokine production was determined from
cell culture supernatants by sandwich ELISA method as
previously described (Miettinen et al., 1996). Antibody pairs
for CCL2, CCL5, CXCL8 and CXCL10 were obtained from
BD Pharmingen (San Diego, CA) and used according to the
instructions provided by the manufacturer.
Western blotting and antibodies
SDS-PAGE was conducted using the Laemmli buffer
system. Proteins were separated on 8% or 10% SDS-PAGE
and transferred onto Immobilon-P membranes (Millipore
Corporation, Bedford, MA). Specific antibodies were used
to visualize proteins. Guinea pig anti-IRF1 antibodies have
been previously described (Matikainen et al., 1996). Anti-
IRF3, anti-IRF7 and anti-IKK( were prepared in guinea pigs
by immunizing the animals 4 times at 4-week intervals with
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baculovirus-expressed proteins (20 Ag/immunization). The
animals were bled 7 days after the last immunization. Anti-
p50 (sc-7178X) and anti-p65 (sc-103X) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Rabbit anti-NS1 (Chen et al., 1998) and anti-RIG-I
(Imaizumi et al., 2002) antibodies were kindly provided by
Drs. Robert Krug and Tadaatsu Imaizumi, respectively. HRP-
conjugated anti-guinea pig and anti-rabbit secondary anti-
bodies were obtained from DakoCytomation A/S (Glostrup,
Denmark).
DNA affinity binding
Virus-induced activation of transcription factors was studied
by DNA affinity binding method using ISRE and NF-nB
oligonucleotide sequences from the CXCL10 promoter. Cells
were lysed, and samples were treated as described previously
(Rosen et al., 1996). The forward oligonucleotide was 5V-
biotinylated, and aBamHI site was added as a spacer between the
biotin and transcription factor binding sequence. The oligonu-
cleotides used were CXCL10 ISRE 5V-ggatccTGTTTTG-
GAAAGTGAAACCTAATTCAC and CXCL10 NF-nB 5V-
ggatccGCAGAGGGAAATTCCGTAACTTGG. All oligonu-
cleotides were obtained from DNA Technology A/S (Aarhus,
Denmark). Oligonucleotides were annealed in 0.5 M NaCl and
incubated with streptavidin–agarose beads (Pierce, Rockford,
IL) at +4 -C for 2 h. The unbound oligonucleotide was
washed, after which equal amounts of protein samples were
incubated with the oligonucleotide bound agarose beads for 2
h at +4 -C. After washings, the bound proteins were boiled in
SDS sample buffer and separated on SDS-PAGE followed by
Western blotting.
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